Biblio
Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. Stem Cell Reports. 2023.
Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells. Lab Chip. 2024.
Modeling Congenital Heart Disease Using Pluripotent Stem Cells. Curr Cardiol Rep. 2020;22(8):55.
. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells. Curr Cardiol Rep. 2022.
. Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19. Circ Res. 2023;132(10):1405-1424.
. MAFA and T3 drive maturation of both fetal human islets and insulin-producing cells differentiated from hESC. J Clin Endocrinol Metab. 2015:jc20152632.
. Islet Neogenesis: A Possible Pathway for Beta-Cell Replenishment. Rev Diabet Stud. 2012;9(4):407-416.
. . Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine. Curr Treat Options Cardiovasc Med. 2015;17(10):404.
. The ethics of publishing human germline research. Nat Biotechnol. 2015;33(6):590-592.
. Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation. J Vis Exp. 2015;(97).
. Chemically Defined Production of Tri-Lineage Human iPSC-Derived Cardiac Spheroids. Curr Protoc. 2023;3(5):e767.
. Biomanufacturing in low Earth orbit for regenerative medicine. Stem Cell Reports. 2021.
A biodegradable microgrooved and tissue mechanocompatible citrate-based scaffold improves bladder tissue regeneration. bioRxiv. 2024.
The Benefits of Stem Cell Biology and Tissue Engineering in Low-Earth Orbit. Stem Cells Dev. 2024.
.